Werlang Monia E, Palmer William C, Lacy Brian E
Dr Werlang is a gastroenterology and hepatology fellow and Dr Palmer and Dr Lacy are senior associate consultants at Mayo Clinic in Jacksonville, Florida.
Gastroenterol Hepatol (N Y). 2019 Jan;15(1):16-26.
Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder, affecting approximately 14% of the global population. Symptoms of IBS are some of the most common reasons that primary care providers refer patients to gastroenterologists. IBS has a significant economic impact on the health care system and greatly reduces patients' quality of life. The precise cause of IBS remains unknown, but likely involves a variety of factors, such as infection, inflammation, medication, and stress, in a genetically predisposed individual. Physicians can diagnose patients with IBS by obtaining a careful history and physical examination, performing limited testing, and applying the Rome IV criteria. Treating IBS symptoms can be challenging, as no medication cures the disorder. Thus, treatment focuses on improving symptoms and quality of life. Many patients report that symptoms develop from, or are exacerbated by, food. A number of physiologic and biochemical processes can occur with food ingestion that may produce heightened symptoms of IBS. Therefore, dietary interventions to improve IBS symptoms appear to be a reasonable treatment approach. This article discusses the evidence supporting dietary interventions for the treatment of IBS.
肠易激综合征(IBS)是最常见的功能性胃肠疾病,影响着全球约14%的人口。IBS的症状是初级保健提供者将患者转诊给胃肠病学家的一些最常见原因。IBS对医疗保健系统有重大经济影响,并大大降低患者的生活质量。IBS的确切病因尚不清楚,但在具有遗传易感性的个体中,可能涉及多种因素,如感染、炎症、药物和压力等。医生可以通过详细询问病史、进行体格检查、开展有限的检查并应用罗马IV标准来诊断IBS患者。治疗IBS症状具有挑战性,因为没有药物可以治愈这种疾病。因此,治疗的重点是改善症状和生活质量。许多患者报告症状由食物引发或因食物而加重。进食时可能会发生一些生理和生化过程,这些过程可能会使IBS症状加剧。因此,通过饮食干预来改善IBS症状似乎是一种合理的治疗方法。本文讨论了支持饮食干预治疗IBS的证据。